Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 5;18(7):3783.
doi: 10.3390/ijerph18073783.

Comparison of Mean Platelet Counts in Preterm Infants with and without Retinopathy of Prematurity

Affiliations

Comparison of Mean Platelet Counts in Preterm Infants with and without Retinopathy of Prematurity

Zi Di Lim et al. Int J Environ Res Public Health. .

Abstract

Platelets are a primary source of pro- and anti-angiogenic cytokines. However, the evidence of their role in retinopathy of prematurity (ROP) is controversial. This retrospective study aimed to compare mean weekly platelet counts between infants with and without ROP over the first 6 weeks of life. A total of 93 infants matched by gestational age and birth weight were recruited (31 with ROP, 62 without ROP). Weekly mean platelet counts and other related risk factors were documented. The repeated measure analysis of variance (ANOVA) and the repeated measure analysis of covariance (ANCOVA) were used to compare mean platelet counts over time between the two groups, with and without adjusting for confounders. We found significant differences in the weekly mean platelet counts of infants with and without ROP over the first 6 weeks of life (p = 0.002). These differences disappeared after adjusting for covariates (p = 0.489). Lower mean platelet counts in ROP infants are not directly related to ROP, but rather to the presence of other risk factors for ROP, such as culture-proven sepsis, blood transfusion and bronchopulmonary dysplasia.

Keywords: infant; platelet count; premature; retinopathy of prematurity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mean platelet count in groups with and without retinopathy of prematurity (ROP) from birth to week 6 of life pre-and postadjustment for confounders (culture-proven sepsis, blood transfusion and bronchopulmonary dysplasia). This graphical depiction of the weekly mean platelet count in infants with and without ROP demonstrates that the difference between the two groups disappears after adjusting for covariates.

References

    1. Gilbert C., Fielder A., Gordillo L., Quinn G., Semiglia R., Visintin P., Zin A. Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs. Pediatrics. 2005;115:e518–e525. doi: 10.1542/peds.2004-1180. - DOI - PubMed
    1. Blencowe H., Lawn J.E., Vazquez T., Fielder A., Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr. Res. 2013;74:35–49. doi: 10.1038/pr.2013.205. - DOI - PMC - PubMed
    1. William V. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans. Am. Ophthalmol. Soc. 2004;102:233–250. - PMC - PubMed
    1. Al-Qahtani B., Al-Otaibi M., Alabdulajabbar K., Bin Selayem N., AlShehri W., Omair A., AlSaif S. Retinopathy of Prematurity Incidence and Risk Factors in a Tertiary Hospital in Riyadh, Saudi Arabia. Middle East Afr. J. Ophthalmol. 2019;26:235–239. doi: 10.4103/meajo.MEAJO_131_18. - DOI - PMC - PubMed
    1. AlBalawi H.B., AlBalawi N.S., AlSuhaimi N.A., AlBalawi A.A., Alatawi A.S., Mirghani H.O., Al-Dhibi H.A., Alenezi S.H. Incidence and risk factors for retinopathy of prematurity in Tabuk city, KSA. Middle East Afr. J. Ophthalmol. 2020;27:105–109. doi: 10.4103/meajo.MEAJO_195_19. - DOI - PMC - PubMed

Publication types

LinkOut - more resources